Figure 1.
Kaplan–Meier overall survival estimates by tumor integrated diagnosis and WHO CNS grade, including IDH-wildtype glioblastoma (WHO grade 4; ie, IDHwt GBM), IDH-mutant astrocytoma (WHO grades 2–4; ie, IDHmut astro), IDH-mutant and 1p/19q-codeleted oligodendroglioma (WHO grades 2–3; ie, IDHmut oligo), and H3 K27M-mutant diffuse midline glioma (DMG).